Ascendis Pharma A/S
ASND
33 hedge funds and large institutions have $158M invested in Ascendis Pharma A/S in 2015 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 8 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
8% more capital invested
Capital invested by funds: $146M → $158M (+$11.8M)
8% less funds holding
Funds holding: 36 → 33 (-3)
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$15.6M |
| 2 |
RIM
RS Investment Management
San Francisco,
California
|
+$5.22M |
| 3 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$3.58M |
| 4 |
SCM
Sio Capital Management
New York
|
+$3.54M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$3.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$8.68M |
| 2 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$5.56M |
| 3 |
DM
Deerfield Management
New York
|
-$3.13M |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$2.28M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.22M |
ASND Hedge Fund Activity: Q2 2015 in Review
33 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Ascendis Pharma A/S (ASND) for Q2 2015, worth a combined $158M — up 8.1% from $146M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ASND and 5 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 8 added.
The largest buyer was RA Capital Management, adding an estimated $15.6M. The largest seller was Sectoral Asset Management, cutting an estimated $8.68M.
- 33 institutional investors held Ascendis Pharma A/S (ASND) as of Q2 2015, down from 36 in Q1 2015.
- Funds reported $158M of Ascendis Pharma A/S stock for Q2 2015, up 8.1% quarter-over-quarter.
- 5 funds opened new Ascendis Pharma A/S positions in Q2 2015 and 8 closed out, a net change of -3 holders.
- The largest Ascendis Pharma A/S buyer in Q2 2015 was RA Capital Management, an estimated $15.6M added.
- The largest Ascendis Pharma A/S seller in Q2 2015 was Sectoral Asset Management, an estimated $8.68M sold.
Based on aggregated 13F filings for Q2 2015.